I had a visual appointment with my MS specialist yesterday. She is the one who prescribes and advises on my main MS drug therapy. Currently I am on Rituxan. The question of my disability getting worse really isn’t a question, it is a fact. We’ve discussed other drugs but unfortunately the one she was waiting for is still a few years off. That’s the Ibudilast. She did yesterday for the first time mention Mavenclad.
In all honesty I didn’t know much about it because I had my head waiting for the Ibudilast or even stem cells. So she told me. It is an oral drug taken for four or five days and then a month later taken again. That is it for an entire year. https://www.mavenclad.com/en/now-approved/?utm_source=GOOGLE&utm_medium=cpc&utm_campaign=2019+Brand+Core%3BS%3BPH%3BBR%3BNER%3BDTC%3BBR&utm_content=Core_Core_Phrase&utm_term=mavenclad&gclsrc=aw.ds&&&gclid=CjwKCAjw98rpBRAuEiwALmo-yhKEBQAJn6dXSWUl2_ScH8yOge3OrOsnm96MMgpEpQALDSPwp5Bw-hoCfTkQAvD_BwE.
Mavenclad is a compound that targets certain types of white blood cells (lymphocytes) that drive the immune attack in MS. It temporarily reduces the number of both T and B lymphocytes without continuous suppression of the immune system. www.nationalmssociety.org
It seriously reduces the immune system so chance of infection is greater. However that wasn’t the issue for me, it was the serious side effects that made me pause. There is an increased risk of cancer with this drug.
I stopped Ocrevus to go back to Rituxan because of the small possibility of cancer. I don’t think my body could fight MS and cancer so I said no to the drug. Sometimes the disability actually weighs more as a plus when other illnesses can become a higher risk. I’d rather be disabled. This drug wasn’t for me but I gave you links to make your own decisions.